What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025? For our March Global Whispers webinar, Clare Foy (Director – Global Market Access, Mtech Access) interviewed Don Husereau (Adjunct Professor of Medicine, The University of Ottawa).
In this webinar, we take a look at the market access, health policy, and health technology assessment in Canada. Clare Foy and Don Husereau explore:
- The market access landscape in Canada
- Upcoming changes at CADTH
- What Canadian payers expect from your value proposition
- Opportunities and challenges when launching new medicines/medical devices/diagnostics in Canada
- How Canada compares to the USA/key European launch markets
- What this means for your global market access strategy
Listen to the podcast:
This episode is also available as a podcast. Listen below or search ‘Pharma Market Access Insights – from Mtech Access’ on Spotify, Apple Podcasts or Google Podcasts.
More about our speaker
Don Husereau (Adjunct Professor of Medicine, The University of Ottawa)
Don is an Adjunct Professor of Medicine at The University of Ottawa. He is a freelance healthcare researcher, and works with private and public sector life sciences organisations to help them understand the value of health technology and its implications for pricing, reimbursement, and healthcare and innovation policy. In Canada, he has served on National and Provincial Expert appraisal committees and has been an invited expert member of a Federal commission focused on innovation policy. He is also Co-Chair of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Task Force.
We are delighted to welcome Don to the Global Whispers webinar series.
The Global Whispers webinar series
This webinar is part of our Global Whispers series where we explore global market access trends and challenges facing the Pharmaceutical and Medtech industries and offer insights into key launch markets.
Our previous webinars are available on demand:
- January 2024: ‘Setting your product up for success – commercialisation strategy for the US market’ with guest speaker Janice MacLennan (Pharma and Medtech brand strategist and founder of NMBLR)
- October 2023: ‘Market Access in Italy: Exploring the potential impact of the AIFA reforms’ with guest speaker Prof. Fabrizio Gianfrate (Professor of HEOR and Ex-Payer)
- August 2023: ‘Artificial intelligence (AI) in clinical trials: Implications for evidence synthesis and market access’ with guest speaker George Magrath (CEO, Lexitas)
- July 2023: ‘Market access in the German-speaking markets’ with guest speaker Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH)
- June 2023: ‘Market access for digital therapies and digital medicines’ with guest speaker Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze)
- May 2023: ‘A global market access journey: What it takes to bring a cannabinoid pharmaceutical to market’ with guest speaker Michael Sassano (CEO – SOMAÍ Pharmaceuticals)
